↓ Skip to main content

A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress in vivo and in vitro

Overview of attention for article published in Frontiers in Pharmacology, July 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
38 Mendeley